LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

C-pyrazole 2A A receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

C-pyrazole A 2A receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

C-pyrazole A2A receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

C-pyrazole a2a receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-substituted tricyclic isoxazoline derivatives and their...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal amide cyclic renin inhibitors containing peptide isos

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal ketone inhibitors of matrix metalloproteinases and TN

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (n-substituted)-2-indolyl dipeptides as inhi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (N-substituted)-2-indolyl dipeptides as inhi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (N-substituted)-2-indolyl dipeptides as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C-terminal modified (N-substituted)-2-indolyl dipeptides as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminus modified heptapeptide LHRH analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C.25 [substituted(2-propenyl)]milbemycins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C.sub.3 substituted trioxanes useful as antiparasitic drugs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

C.sub.4 -amide substituted compounds and their use as therapeuti